Title of article
Crystal Structures of Candida albicans N-Myristoyltransferase with Two Distinct Inhibitors Original Research Article
Author/Authors
Satoshi Sogabe، نويسنده , , Miyako Masubuchi، نويسنده , , Kiyoaki Sakata، نويسنده , , Takaaki A. Fukami، نويسنده , , Kenji Morikami، نويسنده , , Yasuhiko Shiratori، نويسنده , , Hirosato Ebiike، نويسنده , , Kenichi Kawasaki، نويسنده , , Yuko Aoki، نويسنده , , Nobuo Shimma، نويسنده , , Allan DʹArcy، نويسنده , , Josef Jiricny and Fritz K. Winkler، نويسنده , , David W. Banner، نويسنده , , Tatsuo Ohtsuka، نويسنده ,
Issue Information
ماهنامه با شماره پیاپی سال 2002
Pages
10
From page
1119
To page
1128
Abstract
Myristoyl-CoA:protein N-myristoyltransferase (Nmt) is a monomeric enzyme that catalyzes the transfer of the fatty acid myristate from myristoyl-CoA to the N-terminal glycine residue of a variety of eukaryotic and viral proteins. Genetic and biochemical studies have established that Nmt is an attractive target for antifungal drugs. We present here crystal structures of C. albicans Nmt complexed with two classes of inhibitor competitive for peptide substrates. One is a peptidic inhibitor designed from the peptide substrate; the other is a nonpeptidic inhibitor having a benzofuran core. Both inhibitors are bound into the same binding groove, generated by some structural rearrangements of the enzyme, with the peptidic inhibitor showing a substrate-like binding mode and the nonpeptidic inhibitor binding differently. Further, site-directed mutagenesis for C. albicans Nmt has been utilized in order to define explicitly which amino acids are critical for inhibitor binding. The results suggest that the enzyme has some degree of flexibility for substrate binding and provide valuable information for inhibitor design.
Journal title
Chemistry and Biology
Serial Year
2002
Journal title
Chemistry and Biology
Record number
1158561
Link To Document